611O Abiraterone acetate plus prednisolone for hormone-naïve prostate cancer (PCa): Long-term results from metastatic (M1) patients in the STAMPEDE randomised trial (NCT00268476)

Authors :: Matthew R. Sydes
Noel W. Clarke
H. Rush
Alison Birtle
Silke Gillessen
Jacob Tanguay
D. Sheehan
Robin Millman
G. Attard
David P. Dearnaley
Adrian Cook
Joe M. O'Sullivan
Mona Parmar
Zafar Malik
Carmel Pezaro
J. Gale
Simon Chowdhury
Robert Jones
Nicholas D. James
Alex Hoyle
Source :: Annals of Oncology. 31:S509
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Abiraterone acetate
Hematology
Long term results
medicine.disease
Prostate cancer
chemistry.chemical_compound
chemistry
Internal medicine
medicine
Prednisolone
Hormone naive
business
medicine.drug

Tools